Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
KRSA
NGEN
Add up to 3 more stocks
KRSA
Korsana Biosciences, Inc.
+1.97%
$31.32+0.61Delayed quote: Oct 6, 2026, 11:49 AM EDT
Market Cap
$146.64M
52W Range
$7.19 - $59.36
NGEN
NervGen Pharma Corp. Common stock
N/A
$1.81N/ADelayed quote: Oct 6, 2026, 11:49 AM EDT
Market Cap
$148.77M
52W Range
$1.58 - $6.30
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 28.83 | 12.21 |
| P/S Ratio | 77.18 | N/A |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 100.0% | 0.0% |
| Operating Margin | -239.8% | 0.0% |
| Net Margin | -353.0% | 0.0% |
| ROE | -131.8% | -397.4% |
| ROA | -96.8% | -76.1% |
| ROIC | -134.2% | -223.9% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 0.82 | 1.23 |
| Quick Ratio | 0.82 | 1.23 |
| Debt/Equity | 0.00 | 0.00 |
| Interest Coverage | N/A | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.